L&C Bio Co., Ltd (290650.KQ)

KRW 22450.0

(-1.54%)

Operating Income Summary of L&C Bio Co., Ltd

L&C Bio Co., Ltd's latest annual operating income in 2023 was 6.66 Billion KRW , down -29.7% from previous year.
L&C Bio Co., Ltd's latest quarterly operating income in 2024 Q2 was 1.01 Billion KRW , up 19.47% from previous quarter.
L&C Bio Co., Ltd reported an annual operating income of 9.48 Billion KRW in 2022, down -27.99% from previous year.
L&C Bio Co., Ltd reported an annual operating income of 13.16 Billion KRW in 2021, up 79.81% from previous year.
L&C Bio Co., Ltd reported a quarterly operating income of 1.01 Billion KRW for 2024 Q2, up 19.47% from previous quarter.
L&C Bio Co., Ltd reported a quarterly operating income of 2.12 Billion KRW for 2023 Q1, down -30.89% from previous quarter.

Annual Operating Income Chart of L&C Bio Co., Ltd (2023 - 2015)

Historical Annual Operating Income of L&C Bio Co., Ltd (2023 - 2015)

Year	Operating Income	Operating Income Growth
2023	6.66 Billion KRW	-29.7%
2022	9.48 Billion KRW	-27.99%
2021	13.16 Billion KRW	79.81%
2020	7.32 Billion KRW	-18.91%
2019	9.03 Billion KRW	64.9%
2018	5.47 Billion KRW	12.43%
2017	4.87 Billion KRW	134.99%
2016	2.07 Billion KRW	84.6%
2015	1.12 Billion KRW	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	1.64 Billion KRW	270.92%
2024 Q2	1.01 Billion KRW	19.47%
2023 Q1	2.12 Billion KRW	-30.89%
2023 Q4	-962.24 Million KRW	-120.24%
2023 FY	6.66 Billion KRW	-29.7%
2023 Q2	1.61 Billion KRW	-23.93%
2023 Q3	4.75 Billion KRW	194.65%
2022 Q2	2.21 Billion KRW	8.98%
2022 FY	9.48 Billion KRW	-27.99%
2022 Q4	3.06 Billion KRW	41.15%
2022 Q3	2.17 Billion KRW	-1.71%
2022 Q1	2.02 Billion KRW	-52.92%
2021 Q2	3.67 Billion KRW	85.54%
2021 Q3	3.19 Billion KRW	-13.15%
2021 Q4	4.31 Billion KRW	34.9%
2021 FY	13.16 Billion KRW	79.81%
2021 Q1	1.98 Billion KRW	58.56%
2020 Q3	2.41 Billion KRW	23.76%
2020 Q4	1.25 Billion KRW	-48.27%
2020 FY	7.32 Billion KRW	-18.91%
2020 Q1	1.66 Billion KRW	-39.55%
2020 Q2	1.95 Billion KRW	17.55%
2019 Q4	2.75 Billion KRW	34.65%
2019 FY	9.03 Billion KRW	64.9%
2019 Q3	2.04 Billion KRW	-16.55%
2019 Q2	2.44 Billion KRW	36.56%
2019 Q1	1.79 Billion KRW	44.53%
2018 Q2	1.56 Billion KRW	1.84%
2018 Q1	1.54 Billion KRW	0.0%
2018 Q3	1.12 Billion KRW	-28.12%
2018 Q4	1.23 Billion KRW	9.95%
2018 FY	5.47 Billion KRW	12.43%
2017 FY	4.87 Billion KRW	134.99%
2016 FY	2.07 Billion KRW	84.6%
2015 FY	1.12 Billion KRW	0.0%

Peer Operating Income Comparison of L&C Bio Co., Ltd

Name	Operating Income	Operating Income Difference
Osang Healthcare Co.,Ltd	142.82 Billion KRW	95.332%
InBody Co.,Ltd	44.46 Billion KRW	85.008%
Curexo Inc.	1.13 Billion KRW	-487.159%
Seegene, Inc.	-30 Billion KRW	122.216%
i-SENS, Inc.	10.92 Billion KRW	39.001%
Ray Co., Ltd.	6.11 Billion KRW	-8.964%
Gencurix Inc.	-12.37 Billion KRW	153.869%
Sugentech Inc.	-22.74 Billion KRW	129.315%